We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go: Extended investment: Withheld
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go: Extended investment: £295,000
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go: TBC investment: £127,001
Clean Slate is a 100% plant based all day dining concept.  The idea is to create easy attractive plant based eating not just for vegetarians and vegans.  They are lookng for funding to launch a restaurant with the view to open four restaurants over the next four years. (EIS Partial)
days to go: Expired investment: £36,290
A premium British handcrafted candy-maker seeking funds to expand and grow their business internationally. In addition to their own candy and confectionary, they also offer customers to create their own designs using natural colourings and the finest ingredients. Spun Candy have the rights to the Candy Crush app.

Pitch Rated

62%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £341,990
Postio is a secure, dynamic, community driven delivery system. Postio offer the option of same-day and within-the-hour delivery to all. Sending and receiving parties are able to track their driver and therefore their package in realtime.  
days to go: Expired investment: £35,220
Cook My Grub (CMG) is an online food delivery marketplace that offers fresh and authentic home-cooked food using Artificial Intelligence (AI) and Machine Learning (ML). CMG allows customers to choose their food from options such as vegetarianism, veganism, halal, and gluten-free. Customers can use CMG's app to order food on the same day or pre-order several days or even weeks in advance. CMG points out that it sets up 'Virtual Restaurants' for home-chefs giving them the flexibility to decide when, what, and how much they aim to cook. It aims to be a contender in the £10+ billion UK restaurant delivery market. CMG argues that it has served 1300+ meals across Maidenhead, Windsor, and Slough. It has planned future expansion across London, Reading, Swindon, and Home Counties. The company has featured in publications like BBC Berkshire Radio, Public Sector Catering, Business Cloud, and TechFound. It will use the investment to increase marketing, scale-up operations, and grow its technology teams.

Pitch Rated

42%

Insufficient Data

rating powered by

CROWD RATING™

days to go: Expired investment: £685,544
By The Horns Brewing Co are an award-winning brewery in SW London. They are now working at capacity with a range of 6 core beers and exports into 4 countries so are looking to expand and install their own canning and bottling facilities and enhance their tap-room bar.
days to go: Expired investment: £107,520
Book My Garage has been launched to help the independent garage market in winning the online race by giving them all the tools to keep their business profitable, win new customers and to keep their diary full.
days to go: Expired investment: £668,189
The world's first alcoholic drinks company adding collagen to spirits with an elegant and refined taste. This unique recipe has stayed true to the principles of a classic gin but with a rejuvenating twist of anti-ageing botanicals such as pink grapefruit, star anise and fresh orange, with the innovative addition of pure collagen. The collagen market is estimated to be worth $6.63bn by 2025. Till now, 27,000 bottles sold, secured over 200 UK stockists including Ocado & Amazon, successful tastings at Taste London, BBC Good Food and appeared in over 300 media outlets including Lorraine, Sky News, Vogue, Daily Telegraph and Sunday Times. With the proceeds, they will launch internationally, maximise untapped UK opportunities and aim to become the leader in the new and evolving collagen markets.

Pitch Rated

42%

Insufficient Data

rating powered by

CROWD RATING™

days to go: Expired investment: £26,700
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph